

[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
[ Thu, May 16th 2024
] - WOPRAI
Robert Burns Maintained (ALLO) at Strong Buy with Decreased Target to $9 on, May 16th, 2024
Robert Burns of HC Wainwright & Co., Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Decreased Target from $10 to $9 on, May 16th, 2024.
Robert has made no other calls on ALLO in the last 4 months.
There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Benjamin Burnett of "Stifel" Maintained at Hold with Increased Target to $4.6 on, Tuesday, May 14th, 2024
These are the ratings of the 3 analyists that currently disagree with Robert
- Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy and Held Target at $17 on, Wednesday, May 15th, 2024
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $10 on, Friday, March 15th, 2024
- Brian Cheng of "JP Morgan" Maintained at Buy with Decreased Target to $8 on, Tuesday, February 27th, 2024
Contributing Sources